$41.57
3M Ago | 1M Ago | Current | |
Buy | 7 | 7 | 7 |
Outperform | 4 | 4 | 4 |
Hold | 1 | 1 | 1 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
The latest share price target for Protagonist Therapeutics Inc (PTGX) is $46.8, offered by 12 analysts offering 12-month price forecasts.
Protagonist Therapeutics Inc (PTGX) has a maximum of 0.13 upside potential, based on 12 analysts offering 12-month price forecasts.
Based on 12 analysts tracking and researching Protagonist Therapeutics Inc (PTGX), 91.67% have a buy recommendation. Remaining 8.33% have either sell or hold recommendations.
The latest share price of Protagonist Therapeutics Inc (PTGX) is $41.57 as of 26/07/2024.
11 of total 12 analysts offering stock ratings for Protagonist Therapeutics Inc PTGX have recommended buy rating.